Latest News and Events

GeoVax Enters Into Research Collaboration Agreement with the NIH for Ebola/Marburg Vaccines
Collaboration with the National Institute of Allergy and Infectious Diseases to Provide Facilities,...
Continue Reading...
GeoVax to Seek Dual Pathway for Advancing Its HIV Preventive Vaccine
Strategy Intended to Accelerate Development of an HIV Vaccine for the Americas and Western Europe ...
Continue Reading...
GeoVax Provides Details of Presentation at World Vaccine Congress
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing innovative human vaccines for Eb...
Continue Reading...

Dr. Harriet Robinson, Ph.D. ASM Lecture